JIC
MD icon

Joel Isaacson & Co’s Pediatrix Medical MD Stock Holding History

Joel Isaacson & Co’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-95
Closed -$6K – 383
2016
Q4 		$6K Hold
95
– – ﹤0.01% 551
2016
Q3 		$6K Hold
95
– – ﹤0.01% 600
2016
Q2 		$7K Hold
95
– – ﹤0.01% 575
2016
Q1 		$6K Hold
95
– – ﹤0.01% 631
2015
Q4 		$7K Buy
+95
New +$7.03K ﹤0.01% 590

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Joel Isaacson & Co's MD Position: Q1 2017 in Review

Joel Isaacson & Co sold out of Pediatrix Medical (MD) in Q1 2017, closing a stake of 95 shares — an estimated $6K sold.

Joel Isaacson & Co first reported a position in MD in Q4 2015 and held it in 5 quarters. The position peaked at $7K in Q2 2016. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

  • Joel Isaacson & Co reported no remaining Pediatrix Medical position as of Q1 2017 after selling out during the quarter.
  • Joel Isaacson & Co sold 95 Pediatrix Medical shares in Q1 2017, an estimated $6K.
  • Joel Isaacson & Co first reported a position in Pediatrix Medical in Q4 2015 and held it in 5 quarters.
  • Joel Isaacson & Co's Pediatrix Medical position peaked at $7K in Q2 2016.
  • 359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Joel Isaacson & Co's 13F filing for Q1 2017, filed 5 May 2017.